CIK 0001628908
- Large accelerated filer
Evolent Health, Inc.
Sign in to watch- Ticker
- EVH
- Exchange
- NYSE
- Industry
- Services-Management Services
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 320454912
- Phone
- +1 571-389-6000
- Business address
- 1812 NORTH MOORE ST, SUITE 1705, ARLINGTON, VA, 22209
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $329,460
- in 1 filing, $329K under 10b5-1 plans
Net −$329,460. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 74 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2018-02-01 | WILLIAMS FRANK J Chief Executive Officer | Grant or award · Class A Common Stock Option (right to buy) | +227,273 | 227,273 | ||
| 2017-10-02 | DUFFY MARY BRIDGET Director | Grant or award | +6,684 | 6,684 | ||
| 2017-08-03 | WILLIAMS FRANK J Chief Executive Officer | Sale | −16,300 | $23.73 | $387K | 801,583 |
| 2017-08-01 | WIGGINTON STEVE CEO, Valence Health | Exercise or conversion | +6,000 | $3.84 | $23K | 18,411 |
| 2017-08-01 | WIGGINTON STEVE CEO, Valence Health | Sale | −6,000 | $24.64 | $148K | 12,411 |
| 2017-08-01 | WIGGINTON STEVE CEO, Valence Health | Exercise or conversion · Class A Common Stock Option (right to buy) | −6,000 | 399,680 | ||
| 2017-07-24 | Peterson Thomas III Chief Operating Officer | Exercise or conversion | +14,033 | $3.84 | $54K | 153,318 |
| 2017-07-24 | Peterson Thomas III Chief Operating Officer | Sale | −14,033 | $26.00 | $365K | 139,285 |
| 2017-07-24 | Peterson Thomas III Chief Operating Officer | Sale | −26,507 | $26.00 | $689K | 112,778 |
| 2017-07-24 | Peterson Thomas III Chief Operating Officer | Exercise or conversion · Class A Common Stock Option (right to buy) | −14,033 | 178,274 | ||
| 2017-07-10 | McGrane Nicholas Chief Financial Officer | Exercise or conversion | +1,667 | $3.84 | $6K | 33,256 |
| 2017-07-10 | McGrane Nicholas Chief Financial Officer | Sale | −1,667 | $25.42 | $42K | 31,589 |
| 2017-07-10 | McGrane Nicholas Chief Financial Officer | Exercise or conversion · Class A Common Stock Option (right to buy) | −1,667 | 209,618 | ||
| 2017-07-06 | WILLIAMS FRANK J Chief Executive Officer | Sale | −15,050 | $24.72 | $372K | 819,133 |
| 2017-07-06 | WILLIAMS FRANK J Chief Executive Officer | Sale | −1,250 | $25.27 | $32K | 817,883 |
| 2017-07-03 | WIGGINTON STEVE CEO, Valence Health | Exercise or conversion | +6,000 | $3.84 | $23K | 18,411 |
| 2017-07-03 | WIGGINTON STEVE CEO, Valence Health | Sale | −6,000 | $25.07 | $150K | 12,411 |
| 2017-07-03 | WIGGINTON STEVE CEO, Valence Health | Exercise or conversion · Class A Common Stock Option (right to buy) | −6,000 | 405,680 | ||
| 2017-06-28 | TPG Growth II Advisors, Inc. 10% owner | Conversion | +3,619,531 | 4,399,629 | ||
| 2017-06-28 | TPG Growth II Advisors, Inc. 10% owner | Sale | −4,279,325 | $25.87 | $110.7M | 120,304 |
Page 29 of 32 · 627 trades